World's Best Scientists 2026 revealed!
Award Badge
Immunology
Australia
2026
Award Badge
Medicine
Australia
2023

D-Index & Metrics

Immunology

D-Index
122
Citations
57600
World Ranking
314
National Ranking
7

Medicine

D-Index
122
Citations
57810
World Ranking
3461
National Ranking
97

Peter C. Doherty publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter C. Doherty sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 581 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter C. Doherty D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter C. Doherty sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 122 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Australia Leader Award
  • 2025 - Research.com Immunology in Australia Leader Award
  • 2023 - Research.com Immunology in Australia Leader Award
  • 2023 - Research.com Medicine in Australia Leader Award
  • 2022 - Research.com Immunology in Australia Leader Award
  • 2008 - Member of the National Academy of Medicine (NAM)
  • 2006 - Fellow of the Royal Society of Edinburgh
  • 2003 - Member of the European Academy of Sciences
  • 2001 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1998 - Member of the National Academy of Sciences
  • 1996 - Nobel Prize for their discoveries concerning the specificity of the cell mediated immune defence
  • 1995 - Albert Lasker Award for Basic Medical Research, Lasker Foundation
  • 1987 - Fellow of the Royal Society, United Kingdom
  • 1986 - Canada Gairdner International Award
  • 1983 - Fellow of the Australian Academy of Science

Overview

Peter C. Doherty is affiliated with the University of Melbourne in Australia and works primarily in the field of Medicine, with a research focus encompassing Immunology, Infectious Diseases, Epidemiology, Genetics, and Political Science and International Relations.

Their research output includes significant work on topics such as:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Influenza Virus Research Studies
  • T-cell and B-cell Immunology
  • COVID-19 epidemiological studies
  • Zoonotic diseases and public health

Recent publications highlight the scope and direction of their investigations. These include:

  • The origins of SARS-CoV-2: A critical review, 2021, Cell
  • The Origin of COVID-19 and Why It Matters, 2020, American Journal of Tropical Medicine and Hygiene
  • Suboptimal SARS-CoV-2−specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype, 2020, Proceedings of the National Academy of Sciences
  • Make science evolve into a One Health approach to improve health and security: a white paper, 2020, One Health Outlook
  • Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients, 2021, Nature Communications

Their collaborations involve frequent coauthors such as Thi H. O. Nguyen, Katherine Kedzierska, Jamie Rossjohn, Stephen J. Kent, and Carolien E. van de Sandt. The predominant publication venues include Proceedings of the National Academy of Sciences, bioRxiv (Cold Spring Harbor Laboratory), Cell, American Journal of Tropical Medicine and Hygiene, and One Health Outlook.

In addition to articles, they have authored books published by MUP eBooks and the Japan Society of Medical Entomology and Zoology. Notable titles are:

  • Empire, War, Tennis and Me, 2022
  • Christo and Jeanne-Claude: In/Out Studio, 2021

Throughout their career, they have received multiple honors, such as:

  • Nobel Prize, 1996, for discoveries concerning the specificity of the cell mediated immune defence
  • Member of the National Academy of Medicine (NAM), 2008
  • Fellow of the Royal Society of Edinburgh, 2006
  • Member of the European Academy of Sciences, 2003
  • Fellow of the American Association for the Advancement of Science (AAAS), 2001
  • Member of the National Academy of Sciences, 1998
  • Albert Lasker Award for Basic Medical Research, 1995
  • Fellow of the Royal Society, United Kingdom, 1987
  • Canada Gairdner International Award, 1986
  • Fellow of the Australian Academy of Science, 1983

Best Publications

  • Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

    R M Zinkernagel;P C Doherty

  • MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

    Rol.M. Zinkernagel;Pete.C. Doherty

  • Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.

    Kazuya Shimoda;Jan van Deursent;Mark Y. Sangster;Sally R. Sarawar

  • Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

    W. E. Thierfelder;J. M. Van Deursen;K. Yamamoto;R. A. Tripp

  • Influenza

    Unknown

  • Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.

    Rolf M. Zinkernagel;Peter C. Doherty

  • Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex.

    Peter C. Doherty;Rolf M. Zinkernagel

  • Specificity of Virus‐Immune Effector T Cells for H‐2K or H‐2D Compatible Interactions: Implications for H‐Antigen Diversity

    P. C. Doherty;R. V. Blanden;R. M. Zinkernagel

  • The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1

    Paul G. Thomas;Pradyot Dash;Jerry R. Aldridge;Ali H. Ellebedy

  • Virus-Specific CD8+ T Cells in Primary and Secondary Influenza Pneumonia

    Kirsten J Flynn;Gabrielle T Belz;John D Altman;Rafi Ahmed

  • Defective Lymphoid Development in Mice Lacking Jak3

    Tetsuya Nosaka;Jan M. A. van Deursen;Ralph A. Tripp;William E. Thierfelder

  • A biological role for the major histocompatibility antigens.

    P.C Doherty;R.M Zinkernagel

  • Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

    R D Cardin;J W Brooks;S R Sarawar;P C Doherty

  • Virus-specific CD8 + T-cell memory determined by clonal burst size

    Sam Hou;Lisa Hyland;Kevin W. Ryan;Allen Portner

  • CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.

    D J Topham;R A Tripp;P C Doherty

  • H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

    Unknown

  • Cell-mediated Protection in Influenza Infection

    Paul G. Thomas;Rachael Keating;Diane J. Hulse-Post;Peter C. Doherty

  • TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection

    Jerry R Aldridge;Carson E Moseley;David A Boltz;Nicholas J Negovetich

  • A question of self-preservation: immunopathology in influenza virus infection.

    Nicole L La Gruta;Katherine Kedzierska;John Stambas;Peter C Doherty;Peter C Doherty

  • Altered peptidase and viral-specific T cell response in LMP2 mutant mice

    Luc Van Kaert;Philip G. Ashton-Rickardt;Maryna Eichelberger;Maria E Gaczynska

  • Clearance of Influenza Virus Respiratory Infection in Mice Lacking Class I Major Histocompatibility Complex-restricted CD8 + T Cells

    Maryna Eichelberger;William Allan;Maarten Zijlstra;Rudolf Jaenisch

  • Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

    Peter C. Doherty;David J. Topham;Ralph A. Tripp;Rhonda D. Cardin

Frequent Co-Authors

Stephen J. Turner
Stephen J. Turner Monash University
Katherine Kedzierska
Katherine Kedzierska University of Melbourne
Paul G. Thomas
Paul G. Thomas St. Jude Children's Research Hospital
Nicole L. La Gruta
Nicole L. La Gruta Monash University
Ralph A. Tripp
Ralph A. Tripp University of Georgia
Jamie Rossjohn
Jamie Rossjohn Monash University
Gabrielle T. Belz
Gabrielle T. Belz University of Queensland
Richard J. Webby
Richard J. Webby St. Jude Children's Research Hospital
Rolf M. Zinkernagel
Rolf M. Zinkernagel University of Zurich
David J. Topham
David J. Topham University of Rochester Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their studies or career in Immunology, exploring related healthcare degrees online can open valuable opportunities. For example, specialized psychiatric programs such as the cheapest pmhnp programs help professionals gain expertise in mental health, an area interconnected with immunological research on neuroinflammation and psychosomatic conditions.

Nurses aiming to elevate their practice often consider various specialties. Knowing the highest paid dnp specialties can guide decision-making toward fields with rewarding financial prospects and impactful roles, including those related to immunology and infectious diseases.

Career mobility is facilitated by programs like the fnp to acute care np bridge program, which enables family nurse practitioners to transition into acute care roles, often involving complex immunological conditions in critical settings.

Additionally, accelerated pathways such as the accelerated rn to np programs offer efficient routes for registered nurses to become nurse practitioners, expanding their scope to include immunology-related patient care and research.

Best Scientists Citing Peter C. Doherty

Trending Scientists

Recently Published Articles